semaglutide issues as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights Semaglutide: The Drug of Today
Description
In 2024, researchers published a study demonstrating programmable microneedle technology capable of sustained semaglutide delivery, highlighting the potential of transdermal GLP-1 administration
Early studies show retatrutide might lead to greater weight loss than Wegovy or Zepbound
PlexusDx provides personalized semaglutide options with genetic insights to support safe weight management alongside inflammatory bowel condition care
Wondering if you can take Wegovy, Mounjaro or other GLP-1 injections early
